Diversity of class 1 integron gene cassette Pc promoter variants in clinical Escherichia coli strains and description of a new P2 promoter variant

  1. Vinué, L. 1
  2. Jové, T. 3
  3. Torres, C. 1
  4. Ploy, M.-C. 23
  1. 1 Universidad de La Rioja
    info

    Universidad de La Rioja

    Logroño, España

    ROR https://ror.org/0553yr311

  2. 2 French Institute of Health and Medical Research
    info

    French Institute of Health and Medical Research

    París, Francia

    ROR https://ror.org/02vjkv261

  3. 3 University of Limoges
    info

    University of Limoges

    Limoges, Francia

    ROR https://ror.org/02cp04407

Revista:
International Journal of Antimicrobial Agents

ISSN: 0924-8579

Año de publicación: 2011

Volumen: 38

Número: 6

Páginas: 526-529

Tipo: Artículo

beta Ver similares en nube de resultados
DOI: 10.1016/J.IJANTIMICAG.2011.07.007 SCOPUS: 2-s2.0-80255136146 WoS: WOS:000296588200011 GOOGLE SCHOLAR

Otras publicaciones en: International Journal of Antimicrobial Agents

Resumen

Gene cassettes of class 1 integrons may be differently expressed depending on the Pc promoter variant as well as occasionally from a second promoter located downstream of Pc, named P2. So far, the distribution of the variants has only been described in an in silico study. In this study, the prevalence of these variants in vivo was analysed in a population of 85 Escherichia coli strains from a variety of phylogenetic groups isolated from healthy subjects and clinical samples in Spain and France from 2004 to 2007. The weakest variants (PcW and PcH1) prevailed (variants associated with the integrase having the most efficient excision activity), whilst the two strongest variants, PcW TGN-10 and PcS, were less frequent. Furthermore, a new variant of P2 associated with PcW was characterised in one integron (harbouring the gene cassette blaOXA-1-aadA1) from a French strain of a healthy subject. This variant was hereafter named P2m3 and shows a G → A substitution in its -10 element (TACAGT to TACAAT), a mutation that doubled the strength of P2 and approached the level of expression of the strong PcWTGN-10 variant. When the correlation between the Pc variants and the origin of the strains was analysed, no significant difference (P < 0.05) was observed in the Pc variant distribution according to the geographic origin or clinical setting. © 2011 Elsevier B.V. and the International Society of Chemotherapy.